Sarcomas are highly metastatic soft tissue and bone cancers and are often difficult to treat. Scientists have had trouble ...

SAINT study is currently investigating intravenous trabectedin plus ipilimumab and nivolumab in the first line for advanced ...

UCLA have created the most extensive collection of patient-derived sarcoma organoids which are miniature versions of a ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have developed the largest collection of sarcoma patient ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have developed the largest collection of sarcoma patient-derived organoids to date that can help improve the understanding of the ...

Fort Worth, Texas, clinical-stage biopharmaceutical company Actuate said elraglusib has shown a favorable safety profile and antitumor activity across several solid tumors, including melanoma, Ewing ...

This case demonstrates the pivotal role of a cohesive multidisciplinary team in navigating the complex care of oncology ...

Dr. Frank Hoffman was appalled by the sheer numbers of cases of early-stage breast cancer that were being missed. Then he had ...

Its proof-of-concept was achieved in soft tissue sarcomas for which the product received a European ... or the negative of these and similar expressions are intended to identify forward-looking ...

Atezolizumab is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Thymic Carcinoma.

Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company), a Phase 3 clinical-stage pharmaceutical company with a ...

Orphan Drug Designation in Soft Tissue Sarcomas Expands Company’s Potential to Address Cancers with High Unmet Medical Need CHICAGO and FORT WORTH, Texas, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Actuate ...